ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹3.39 Cr | ₹3.63 Cr | ₹13 Cr | ₹11 Cr | ₹12 Cr |
What is the latest Long Term Provisions ratio of ORCHID PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹3.39 Cr |
| Mar2024 | ₹3.63 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹12 Cr |
How is Long Term Provisions of ORCHID PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.39 Cr | -6.80 | |
| Mar2024 | ₹3.63 Cr | -71.16 | |
| Mar2023 | ₹13 Cr | 14.43 | |
| Mar2022 | ₹11 Cr | -4.56 | |
| Mar2021 | ₹12 Cr | - | |
Compare Long Term Provisions of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,727.2 Cr | -14.5% | -23.1% | -41.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -14.5% |
-23.1% |
-41.4% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses